ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,327Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 569

$867K Total Retail Price of All Prescriptions

Rank: 5 out of 569

614 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Mexico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 614 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 614 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
OMEPRAZOLE 817 632 137 1 4
HYDROCODONE-ACETAMINOPHEN 797 549 158 S3 2 7
LEVOTHYROXINE SODIUM 702 518 92 3 1
LISINOPRIL 522 418 88 4 2
AMLODIPINE BESYLATE 439 413 60 5 6
FUROSEMIDE 433 323 75 6 11
SIMVASTATIN 431 341 65 7 3
POTASSIUM CHLORIDE 418 307 77 8 26
METOPROLOL TARTRATE 296 261 48 9 14
ATORVASTATIN CALCIUM 293 260 49 10 10
METOPROLOL SUCCINATE 277 222 40 11 15
METFORMIN HCL 260 198 49 12 5
ALPRAZOLAM 259 202 47 B 13 28
ATENOLOL 248 193 34 14 19
TAMSULOSIN HCL 218 181 33 15 22
FENTANYL 208 163 29 S2 16 98
CLOPIDOGREL 200 184 31 17 34
SERTRALINE HCL 199 162 34 18 20
WARFARIN SODIUM 194 142 28 19 27
HYDROCHLOROTHIAZIDE 187 151 34 20 8
TRAMADOL HCL 186 149 42 21 25
GABAPENTIN 184 140 35 22 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 161 30 23 21
CRESTOR 176 171* 22 24 42
RANITIDINE HCL 175 117 27 25 29
NAMENDA 173 <11 <11 26 51
ESCITALOPRAM OXALATE 167 127 34 27 75
MELOXICAM 160 143 33 28 40
ZOLPIDEM TARTRATE 159 140 40 29 18
ALENDRONATE SODIUM 154 130 19 30 16
JANUVIA 152 147* 16 31 49
LOSARTAN POTASSIUM 150 139 29 32 13
ALLOPURINOL 146 121 31 33 37
PRAVASTATIN SODIUM 144 124 25 34 33
GLIMEPIRIDE 142 120 22 35 53
PROAIR HFA 141 99 37 36 30
CYMBALTA 140 140 13 37 66
DIOVAN 138 112 14 38 61
NEXIUM 137 109 20 39 73
CITALOPRAM HBR 134 129* 24 40 23
DONEPEZIL HCL 134 134 23 40 43
KLOR-CON 10 130 96 19 42 152
CEPHALEXIN 129 106 86 43 80
ENALAPRIL MALEATE 128 102 18 44 76
LANTUS 125 70 19 45 46
CARVEDILOL 110 93 20 46 38
FLUOXETINE HCL 105 72 15 47 39
CYCLOBENZAPRINE HCL 103 42 19 R 48 60
PREMARIN 102 97* 15 R 49 112
LORAZEPAM 101 87 27 B 50 41
ISOSORBIDE MONONITRATE ER 101 81 15 50 116
OXYCODONE HCL-ACETAMINOPHEN 99 58 13 S2 52 56
LOVASTATIN 96 59 15 53 12
ROPINIROLE HCL 94 78 13 54 95
ESTRADIOL 93 88* 13 R 55 133
LEVOFLOXACIN 92 81 65 56 110
TEMAZEPAM 89 77 20 B 57 107
SPIRIVA 87 76 13 58 71
CHLORTHALIDONE 85 73 11 59 93
PANTOPRAZOLE SODIUM 85 80* 17 59 36
LOSARTAN-HYDROCHLOROTHIAZIDE 81 76* 15 61 50
ADVAIR DISKUS 80 43 17 62 52
CARISOPRODOL 78 41 14 R 63 94
BUMETANIDE 75 <11 <11 64 210
THEOPHYLLINE ANHYDROUS 75 <11 <11 64 210
RISPERIDONE 75 <11 <11 A 64 102
BISOPROLOL-HYDROCHLOROTHIAZIDE 74 47 13 67 132
TRAZODONE HCL 73 68* 13 68 24
NAPROXEN 73 58 19 68 69
LEVEMIR 70 <11 <11 70 146
GLIPIZIDE 70 <11 <11 70 35
AMITRIPTYLINE HCL 68 24 11 R 72 63
CELEBREX 68 63* 15 72 99
NIFEDIPINE ER 68 68 11 72 140
OXYBUTYNIN CHLORIDE 66 53 16 75 81
AZITHROMYCIN 62 57* 49 76 44
HYDROXYZINE HCL 60 45 12 R 77 106
PROMETHAZINE HCL 60 30 14 R 77 147
VERAPAMIL ER 59 <11 <11 79 137
LEVEMIR FLEXPEN 59 54* 14 79 103
VALSARTAN-HYDROCHLOROTHIAZIDE 59 54* 12 79 114
FINASTERIDE 57 <11 <11 82 57
LYRICA 56 <11 <11 83 117
EVISTA 56 <11 <11 83 153
BD ULTRA-FINE PEN NEEDLE 56 32 15 83 123
DILTIAZEM ER 55 <11 <11 86 154
PIOGLITAZONE HCL 54 <11 <11 R 87 82
DETROL LA 53 <11 <11 88 195
DICLOFENAC SODIUM 52 <11 <11 89 92
AMIODARONE HCL 52 <11 <11 89 249
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.